Logo
  • Chemistry
  • Pharma
  • Strategy
  • Innovation
  • Technology
  • Bioprocessing
  • Digitalization
  • Logistics
  • DE
  • EN
Logo
  • News
  • Topics
  • Books
  • Publication
  • Companies
  • Events
  • Jobs

most read article

Bayer-Standort Bergkamen wird Pharma- und Chemiepark
News • Strategie

Bayer-Standort Bergkamen wird Pharma- und Chemiepark

Bayer will für den Standort Bergkamen eine eigenständige Betreibergesellschaft gründen, die im Laufe des Jahres 2027 starten soll.

And the Winners are: Cynio, EnaDyne und Green Li-ion
News

And the Winners are: Cynio, EnaDyne und Green Li-ion

Der CHEManager Innovation Pitch, die Start-up-Förderinitiative von CHEManager und CHEManager International, hat seit ihrem Launch 2019 mehr als 100 Start-ups aus über 15 Ländern die Möglichkeit geboten, ihre innovativen Ideen, Produkte und Technologien einer breiten Zielgruppe zu präsentieren.

Samsung Biologics Launches CHF 1.46 Billion Tender Offer for PolyPeptide
News • Pharma

Samsung Biologics Launches CHF 1.46 Billion Tender Offer for PolyPeptide

Samsung Biologics has published its formal offer prospectus to acquire PolyPeptide, deepening its push into peptide manufacturing as CDMOs race to expand capacity for GLP-1 and other peptide-based drugs.

Evonik Appoints Claus Rettig as Interim CEO
News

Evonik Appoints Claus Rettig as Interim CEO

Until further notice, Rettig is taking over the duties of Christian Kullmann, who is recovering in the coming weeks from a recent serious, unplanned surgery.

Albert Launches First Chemistry-Native AI Built for Enterprise R&D
News • Technology

Albert Launches First Chemistry-Native AI Built for Enterprise R&D

Albert recently announced Ask Albert, agentic chemistry-native AI built for enterprise R&D, designed to surface scientific knowledge and execute research tasks with accuracy and security.

Evonik Invests €93 Million in Vancouver GMP Plant to Triple LNP Capacity
News • Pharma

Evonik Invests €93 Million in Vancouver GMP Plant to Triple LNP Capacity

New GMP (Good Manufacturing Practice) facility to meet increasing demand for lipid nanoparticle (LNP) development and clinical drug product manufacturing.

Topics

  • Chemistry
  • Pharma
  • Strategy
  • Innovation
  • Technology
  • Bioprocessing
  • Digitalization
  • Logistics
  • Newsletter
  • Contact
  • About us
  • Media Kit
  • Imprint
  • Terms and Conditions
  • Data Protection
  • Virtual Events
  • Issue Preview
Wiley Branding
  • News
  • Topics
  • Books
  • Publication
  • Companies
  • Events
  • Jobs
  • Chemistry
  • Pharma
  • Strategy
  • Innovation
  • Technology
  • Bioprocessing
  • Digitalization
  • Logistics
    • DE
    • EN